Annual report 2023/24

Patents

The Fraunhofer IZI patent portfolio currently consists of 56 patent families (excluding patents held at Fraunhofer IZI-BB), which are available for use in collaborative projects as well as for direct marketing and licensing.

  • Novel delivery systems for nucleic acids
  • Methods for the diagnosis of infectious agents
  • Methods for the diagnosis of cancer
  • New treatment methods for cancer and other diseases 
  • New method for the prevention of graft-versus-host disease (GvHD) 
  • Method for immobilization of cells on surfaces 
  • Mineral compounds for prevention / therapy of kidney and intestinal diseases
  • Method for the preparation of a leukocyte preparation 
  • Biomarkers and diagnostic systems for human or veterinary application 
  • RNA species for therapeutic and / or diagnostic use 
  • Methods and devices for point-of-care diagnostics
  • Agents for the therapy of infectious as well as fibrotic and neurodegenerative diseases
  • New viral vectors for the gene modification of immune cells
  • Surface modification
  • Inactivation of pathogens in the context of vaccine production and novel vaccine candidates
  • Novel ATMPs and methods for their optimization
  • Epitopes from food relevant for the development of allergies and methods for allergen extraction
  • Technologies for microfluidic systems
  • Dialysis methods and novel components of dialysis systems
  • Novel AAV vectors

Kontakt

Thomas Tradler

Contact Press / Media

Dr. Thomas Tradler

Leitung Business Development und Patentmanagement

Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Perlickstr. 1
04103 Leipzig

Phone +49 341 35536-9305

Fax +49 341 35536-89305